Altre lingue CNBX Pharmaceuticals Inc.

Azioni

CNBX

US13764M2098

Mercato chiuso - OTC Markets Altri mercati azionari 21:21:44 06/05/2024			Variaz. 5gg	Var. 1 gen.
0,0102 ^USD	-10,53%		0,00%	-28,17%

16/04	CNBX Pharmaceuticals Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 29 febbraio 2024	CI
12/01	CNBX Pharmaceuticals Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 30 novembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	16/04
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	12/01
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	30/11
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	14/07/23
BigTime Penny Stocks: Unusual "Chatter" Watchlist (GEGI, AAPJ, CNBX, GTVH)	05/06/23
BigTime Penny Stocks: Potential Breakout Stocks - Watchlist (GNPX, CLNV, CNBX, WOEN)	02/06/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	14/04/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	14/04/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	08/02/23
CNBX Pharmaceuticals Inc. Announces Board Resignations	08/02/23
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	13/01/23
CNBX Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	13/01/23
CNBX PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	29/12/22
Shaul Yemal Resigns Position as Director and Board Member Cnbx Pharmaceuticals Inc	29/12/22
CNBX PHARMACEUTICALS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	30/11/22
CNBX Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	30/11/22
CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	30/11/22
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma	08/11/22
CNBX Pharmaceuticals Inc. acquired unknown stake in TaGeza Biopharmaceuticals Ltd.	08/11/22
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy	18/10/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue CNBX Pharmaceuticals Inc.

Azioni

CNBX

US13764M2098

Altre lingue

Filtri